Clinical Scorecard: Comprehensive Genomic and Multi-Omics Approaches Reveal Oxidative Stress Pathways and Potential Therapeutic Targets for Tinnitus
At a Glance
Category
Detail
Condition
Tinnitus
Key Mechanisms
Oxidative stress-mediated immune and metabolic dysregulation involving ACADVL gene
Target Population
Individuals with tinnitus, including those with neuroinflammatory and metabolic abnormalities
Care Setting
Clinical and research settings focusing on genetic and molecular diagnostics and therapeutic development
Key Highlights
Integration of GWAS meta-analysis with multi-omics data identified oxidative stress-related genes linked to tinnitus.
ACADVL gene expression and VLCAD protein levels are elevated in tinnitus patients, implicating metabolic and immune pathways.
Molecular docking suggests fenretinide as a promising repurposable therapeutic agent targeting oxidative stress pathways.
Guideline-Based Recommendations
Diagnosis
Consider genetic and multi-omics profiling to identify oxidative stress-related molecular signatures in tinnitus.
Evaluate oxidative stress markers and immune-metabolic parameters as part of comprehensive tinnitus assessment.
Management
Current interventions remain primarily symptomatic; antioxidant therapies may reduce oxidative damage.
Fenretinide identified as a potential therapeutic candidate targeting ACADVL-mediated pathways.
Monitoring & Follow-up
Monitor changes in oxidative stress biomarkers and immune cell profiles (e.g., CD25 on IgD+CD38− B cells) during treatment.
Assess metabolic ratios such as phosphate-to-oleoyl-linoleoyl-glycerol as indicators of therapeutic response.
Risks
Persistent oxidative stress may exacerbate neuroinflammation and metabolic dysfunction contributing to tinnitus severity.
Comorbid psychiatric and neurological conditions may increase overall disease burden and suicide risk.
Patient & Prescribing Data
Patients diagnosed with tinnitus exhibiting oxidative stress and immune-metabolic dysregulation
Fenretinide shows potential as a repurposable drug targeting oxidative stress pathways; antioxidant interventions may alleviate symptoms but require further clinical validation.
Clinical Best Practices
Incorporate multi-omics and genetic data integration for precise molecular characterization of tinnitus.
Target oxidative stress pathways through antioxidant therapies and novel agents like fenretinide.
Address comorbid psychiatric and neurological conditions to improve overall patient quality of life.
Use validated biomarkers to guide and monitor therapeutic interventions.
